MSME (Udyam registered) Ministry of MSME
- Category
- Small (2024-25)
- Udyam number
- UDYAM-HR-18-0000953
Afflatus Pharmaceuticals Private Limited - healthcare in New Delhi, Delhi, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹35.04 Cr
▲ 23% YoY
Net profit · FY 2025
₹22.36 Lakh
Net margin 0.6%
EBITDA · FY 2025
₹1.22 Cr
EBITDA margin 3.5%
Authorised capital
₹2 Cr
Registered with MCA
Paid-up capital
₹2 Cr
Issued & subscribed
Open charges
₹9.28 Cr
Satisfied ₹3 Cr
Company age
21 yrs
Est. 2005
Employees · EPFO
12
Provident fund records
About Afflatus Pharmaceuticals Private Limited
Data last updated:
Afflatus Pharmaceuticals Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the ayurvedic products and services segment of the healthcare sector. It was incorporated on 08 September 2005 and has been in existence for over 21 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U00304DL2005PTC140510. Its GSTIN is 06AAFCA9906K1ZF (Haryana).
The company has an authorised share capital of ₹2 Cr and a paid-up capital of ₹2 Cr. It was formerly known as Allenbury Biotech Private Limited. It is led by directors Kamal Chhabra and Tilak Raj.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at E – 29 Amar Colonylajpat Nagar IV New Dldehi, New Delhi, Delhi, India – 110024.
As per the financials filed for FY 2025, the company reported a revenue of ₹35.04 Cr, a growth of 23% compared to the previous year. For the same year it recorded a net profit of ₹22.36 Lakh (net margin 0.6%) and EBITDA of ₹1.22 Cr (EBITDA margin 3.5%). Revenue has grown at a compounded annual rate (CAGR) of 60% over three years and 27% over five years.
The company has about 12 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹9.28 Cr and satisfied charges of ₹3 Cr on record. Court records list 10 cases involving the company, including 8 filed by the company and 2 filed against it; 5 cases are pending.
Afflatus Pharmaceuticals Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-HR-18-0000953). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website afflatuspharma.com.
Company details
CIN U00304DL2005PTC140510
Registration Number 140510
Incorporation Date 08 September 2005
ROC Delhi
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-HR-18-0000953
Key People
Kamal Chhabra Director Tilak Raj Director Recognitions & Rankings of Afflatus Pharmaceuticals
Contact details
Afflatus Pharmaceuticals Private Limited's registered office is in New Delhi, Delhi. Its website is afflatuspharma.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered AddressE – 29 Amar Colonylajpat Nagar IV New Dldehi, New Delhi, Delhi, India – 110024
- IndustryHealthcare, Ayurvedic Products & Services
To see the full contact details of Afflatus Pharmaceuticals Private Limited, buy the company report.
Comprehensive company report
Afflatus Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Afflatus Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Afflatus Pharmaceuticals Private Limited, buy the company report.
Financials of Afflatus Pharmaceuticals Private Limited
FY 2025 filings availableAfflatus Pharmaceuticals Private Limited reported revenue of ₹35.04 Cr (up 23% YoY) for FY 2025.
Revenue · FY 2025
₹35.04 Cr ▲ 23%
Net profit · FY 2025
₹22.36 Lakh margin 0.6%
EBITDA · FY 2025
₹1.22 Cr margin 3.5%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 23%
3 years · compounded
▲ 60%
5 years · compounded
▲ 27%
EBITDA CAGR growth
1 year
▲ 18%
3 years · compounded
▲ 88%
5 years · compounded
▲ 37%
Revenue has grown at a compounded annual rate (CAGR) of 27% over five years, including 23% growth in the latest year. EBITDA rose 18% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹1.22 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹22.36 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 3.5% | ||||
| Net Profit Margin | 0.6% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Afflatus Pharmaceuticals Private Limited, buy the company report.
Board of directors of Afflatus Pharmaceuticals Private Limited
Afflatus Pharmaceuticals has 2 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Kamal Chhabra | Director | 23 Apr 2018 | 8 Years 6 Months | Current |
| Tilak Raj | Director | 23 Apr 2018 | 8 Years 6 Months | Current |
Peer comparison
Afflatus Pharmaceuticals Private Limited is compared with the 4 companies closest to it by revenue in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Dr. Miltons Laboratories Private Limited | ₹35.09 Cr (FY 2025) | -2.0% | Chennai, Tamil Nadu, India | |||
| Jawa Pharmaceuticals (India) Pvt. Ltd | ₹35.04 Cr (FY 2025) | 0.0% | Rajasthan, India | |||
| Afflatus Pharmaceuticals Private Limitedthis company | ₹35.04 Cr (FY 2025) | ₹22.36 Lakh | 0.6% | 23.0% | 12 | New Delhi, Delhi, India |
| Value Chem Private Limited | ₹34.86 Cr (FY 2024) | 41.0% | Hyderabad, Telangana, India | |||
| Porus Agro Food Products Private Limited | ₹34.61 Cr (FY 2025) | 19.0% | Hyderabad, Telangana, India |
To see the full peer comparison of Afflatus Pharmaceuticals Private Limited, buy the company report.
Auditor
Afflatus Pharmaceuticals Private Limited is audited by R W L R & ASSOCIATES for the financial year 2024.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| R W L R & ASSOCIATES | FY 2024 | 0031695N |
Shareholding
The shareholding of Afflatus Pharmaceuticals Private Limited is on record for 5 financial years, the latest being FY 2024, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Afflatus Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
Open charges
₹9.28 Cr
Satisfied charges
₹3 Cr
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 30 Apr 2025 | 101089972 | Others | ₹28.39 Lakh | Open | |
| 30 Apr 2025 | 101089978 | Others | ₹1.5 Cr | Open | |
| 20 Dec 2024 | 101022683 | Others | ₹3 Cr | Open | |
| 08 Nov 2023 | 100828548 | Others | ₹1.5 Cr | Open | |
| 01 Sep 2021 | 100480592 | Others | ₹1.5 Cr | Open |
To see the full charge records of Afflatus Pharmaceuticals Private Limited, buy the company report.
Total charge records: 8 View all charges
Legal cases
Afflatus Pharmaceuticals Private Limited has 10 court cases on record: 8 filed by Afflatus Pharmaceuticals, 2 filed against it. 5 cases are pending and 5 are disposed.
Total cases
10
Filed by the company
8
Filed against the company
2
Pending
5
Disposed
5
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 8 | 0 | 5 |
| High courts | 2 | 2 | 0 |
Cases on record (5 of 10)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Sonepat, Haryana | Cheque dishonour complaint | Filed by the company against Nava Health Care Pvt. Ltd. and 3 others | Disposed |
| District court, Sonepat, Haryana | Cheque dishonour complaint | Filed by the company against Ind Swift Ltd. and 1 other | Disposed |
| District court, Chamba, Himachal Pradesh | Court case (Cr. M. A.) | Filed by the company against an individual | Pending |
| District court, Sonepat, Haryana | Cheque dishonour complaint | Filed by the company against M/S N.K.S. Medical Agencies | Pending |
| District court, Sonepat, Haryana | Cheque dishonour complaint | Filed by the company against Junvenor Healthcare Limited and 1 other | Pending |
To see the full case history of Afflatus Pharmaceuticals Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Afflatus Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Afflatus Pharmaceuticals Private Limited has a workforce of 12 employees on its EPFO records as of Feb 17, 2025, across 1 active EPFO establishment.
Employee count
12
Active EPFO establishments
1
Employee growth
20%
GST
Afflatus Pharmaceuticals has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 06AAFCA9906K1ZF | Haryana | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Afflatus Pharmaceuticals Private Limited, buy the company report.
Recent activity
Afflatus Pharmaceuticals Private Limited has 6 board changes on record since 2018: 2 appointments and 4 cessations. The latest: Deepanshu Pruthi ceased to be Director on 13 Jun 2019.
AGM
Afflatus Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Charges
A charge with Others amounted to Rs. 0.28 Cr with Charge ID 101089972 was registered on 30 Apr 2025.
Charges
A charge with Others amounted to Rs. 1.50 Cr with Charge ID 101089978 was registered on 30 Apr 2025.
Filing
Afflatus Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi.
Charges
A charge with Others amounted to Rs. 3.00 Cr with Charge ID 101022683 was registered on 20 Dec 2024.
Charges
A charge with Others amounted to Rs. 1.50 Cr with Charge ID 100828548 was registered on 08 Nov 2023.
Charges
A charge registered on 03 Aug 2021 via Charge ID 100491313 with Hdfc Bank Limited was fully satisfied on 28 Apr 2022.
Charges
A charge with Others of Rs. 1.50 Cr registered on 17 Nov 2018 with Charge ID 100218812 was modified on 24 Mar 2022.
Charges
A charge with Others amounted to Rs. 1.50 Cr with Charge ID 100480592 was registered on 01 Sep 2021.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 2.70 Cr with Charge ID 100491313 was registered on 03 Aug 2021.
Ceased
Deepanshu Pruthi ceased to be Director.
Ceased
Nishchal Pruthi ceased to be Director.
8 earlier events are in the company report.
Frequently asked questions
Afflatus Pharmaceuticals is an active private limited company based in New Delhi, Delhi, India. The company works in ayurvedic products and services, within the healthcare industry. It was incorporated on 08 September 2005 (21+ years old) and is registered under CIN U00304DL2005PTC140510.
Afflatus Pharmaceuticals has 2 current directors:
- Kamal Chhabra - Director
- Tilak Raj - Director
The latest financial statements of Afflatus Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Afflatus Pharmaceuticals is 06AAFCA9906K1ZF, registered in Haryana.
The CIN (Corporate Identification Number) of Afflatus Pharmaceuticals is U00304DL2005PTC140510. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Afflatus Pharmaceuticals has 10 court cases on record: 8 filed by the company and 2 filed against it. 5 are pending. Most are in the district courts.
Afflatus Pharmaceuticals was incorporated on 08 September 2005, making it 21+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Afflatus Pharmaceuticals by revenue are Dr. Miltons Laboratories Private Limited, Jawa Pharmaceuticals (India) Pvt. Ltd, Value Chem Private Limited, Porus Agro Food Products Private Limited, all in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Deepanshu Pruthi ceased to be Director on 13 Jun 2019. Nishchal Pruthi ceased to be Director on 13 Jun 2019. Jaswant Rai Pruthi ceased to be Director on 25 Jun 2018. Afflatus Pharmaceuticals has 6 board changes on record in total.
Yes, Afflatus Pharmaceuticals is registered as a small enterprise under Udyam registration (number: UDYAM-HR-18-0000953).
Afflatus Pharmaceuticals can be reached through the website afflatuspharma.com. Its registered office is in New Delhi, Delhi, India.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages